Home Blog Page 1084

Agoda maps out Asia’s recommended cities to experience spring flower blooms

SINGAPORE, Feb. 6, 2026 /PRNewswire/ — Digital travel platform Agoda highlights a selection of cities across Asia where travelers can experience seasonal flower blooms from March through May. Across different markets, spring brings distinct floral moments that shape local festivals, outdoor spaces, and travel experiences. For travelers planning trips around nature-focused activities, these bloom periods offer a timely reason to explore urban landscapes through a seasonal lens.

Spring travel often centers on slow exploration with park visits and neighborhood walks, and flower blooms create natural settings for these experiences. From tree-lined avenues to hillside gardens, many cities in Asia see plants reach their peak during early and mid-spring, drawing both residents and international visitors outdoors.

Here are Agoda’s spring favorites in Asia for catching breathtaking seasonal blooms that are well worth the trip:

  • Tokyo, Japan welcomes spring with cherry blossom displays across areas such as Ueno Park, Meguro River, and Shinjuku Gyoen, typically from late March into early April. The bloom period aligns with citywide Hanami traditions, where travelers can observe how residents gather beneath flowering trees in public spaces. Seasonal food offerings and riverside walks add to the experience without leaving the city center.
  • Shillong, India comes alive in spring as jacaranda and rhododendron blooms add soft hues of purple and pink across the city’s hills, gardens, and winding roads. Tree-lined Police Bazaar and Lady Hydari Park take on a distinctly seasonal character, while nearby viewpoints and forest trails around Ward’s Lake and Shillong Peak offer scenic backdrops for leisurely walks. The season complements the city’s café culture and short nature excursions, giving travelers a relaxed, nature-infused urban experience in northeast India during spring.
  • Seoul, South Korea follows closely with cherry blossoms appearing in early April. Spots such as Yeouido Hangang Park and Seokchon Lake frame bloom against modern skylines and water views. Travelers can combine flower viewing with café stops and neighborhood exploration, making the city approachable for short spring itineraries.
  • Taipei, Taiwan offers a slightly earlier bloom window, with cherry blossoms appearing from late February into March, particularly in Yangmingshan. The area’s walking trails and thermal valleys provide varied scenery within easy reach of the city, creating a balance between outdoor time and urban comforts during spring travel.
  • Srinagar, India enters the season in April when tulips bloom across the Indira Gandhi Memorial Tulip Garden. Set against mountain backdrops, the gardens form part of a wider spring atmosphere in the region, where houseboat stays, and lakefront walks complement the floral displays.

Andrew Smith, Senior Vice President, Supply at Agoda shared, “Spring travel is about slowing down and seeing cities through a seasonal lens, and flower blooms are a powerful draw for that experience. At Agoda, we’re seeing how these moments influence travel decisions, and with millions of stays, flights, and activities available in one place, we make it easy for travelers to plan and book their perfect spring getaway around nature-filled experiences.”

For travelers planning spring getaways around seasonal scenery, Agoda offers access to over 6 million holiday properties, more than 130,000 flight routes, and over 300,000 activities, all of which can be combined in a single booking. Travelers can find accommodation options near parks, gardens, and city centers, with the best deals available on Agoda’s mobile app. More information can be found at https://www.agoda.com.

EVE Energy “Mr Big” Big Battery Delivers Reliable Energy Storage Power to KLIA

KUALA LUMPUR, Malaysia, Feb. 6, 2026 /PRNewswire/ — EVE Energy Co., Ltd. and its partners signed a contract for the Kuala Lumpur International Airport (KLIA) solar-plus-storage project, with Malaysia’s Deputy Prime Minister Fadillah Yusof in attendance to witness the milestone. This marks EVE Energy’s formal entry into Malaysia’s critical infrastructure sector with its 628Ah energy storage batteries and 5MWh energy storage system,supporting the nation’s green and smart energy transformation.

Oscar Chan, GM of Energy Storage International Sales Department at EVE Energy, and En Harman, President of Cenergi SEA, jointly unveiled the energy storage procurement contract.
Oscar Chan, GM of Energy Storage International Sales Department at EVE Energy, and En Harman, President of Cenergi SEA, jointly unveiled the energy storage procurement contract.

The 10MW/36MWh ground-mounted solar PV + BESS project marks EVE’s first AC/DC integrated energy storage deployment in Malaysia. Equipped with 628Ah batteries and a highly integrated architecture, the system features a planned 5MWh storage system. It is applicable to scenarios such as renewable energy grid connection, peak shaving and grid frequency regulation, and will supply green power to KLIA’s main terminal stably when put into operation in 2027, in conjunction with a 36MWp solar farm.

“We are honored to power a world-class transportation hub like KLIA,” said Oscar Chan, General Manager of EVE Energy’s International Energy Storage Sales. “We will draw on our technical expertise and project experience to ensure the project’s high-quality delivery.”


As Southeast Asia’s second-busiest airport, KLIA serves 6 million passengers annually. Aligned with Malaysia’s National Energy Transition Roadmap (NETR) and carbon reduction goals, EVE’s safe and efficient storage solution is expected to cut approximately 42,006 tons of CO₂ annually, supporting KLIA’s 2030 renewable energy targets and net-zero aspirations.

Moving forward, EVE Energy remains committed to deepening partnerships across Southeast Asia, collaborating with global stakeholders to accelerate clean energy transition and build a sustainable energy ecosystem.

 

Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer

HONG KONG, Feb. 6, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). This latest designation applies to ivonescimab in combination with chemotherapy for the first-line treatment of advanced biliary tract cancer (BTC).

This milestone represents the fifth BTD awarded to ivonescimab by the NMPA, following three prior designations in lung cancer indications and one for triple-negative breast cancer (TNBC). The repeated recognition highlights ivonescimab’s broad clinical potential across multiple high unmet need tumor types.

A randomized, controlled, multicenter, registrational Phase III clinical study (AK112-309/HARMONi-GI1) is evaluating ivonescimab plus chemotherapy versus durvalumab (a PD-L1 inhibitor) plus chemotherapy for first-line treatment of advanced BTC. Patient enrollment has been completed, and the BTD status for this indication underscores the promising clinical profile of ivonescimab. The BTD status is expected to accelerate both the ongoing clinical development and the regulatory review process in China.

Encouraging results from a Phase 1b/II study, presented at the 2024 American Society of Clinical Oncology (ASCO) Annual meeting, support the potential of the ivonescimab combination therapy as a superior first-line treatment for advanced BTC. In the study, ivonescimab plus chemotherapy achieved an Objective Response Rate (ORR) of 63.6% and a Disease Control Rate (DCR) of 100%. The ivonescimab regimen also demonstrated a median Progression-Free Survival (mPFS) of 8.5 months and a median Overall Survival (mOS) of 16.8 months.

These compelling Phase II results provide a robust foundation for the ongoing Phase III registrational trial and reinforce ivonescimab’s potential to address the significant unmet needs in advanced BTC, where current treatment options often yield limited durable responses.

Forward-Looking Statement of Akeso, Inc.
This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

About Akeso
Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its proprietary Tetrabody bispecific antibody platform, ADC (Antibody-Drug Conjugate) technologies, siRNA/mRNA modalities, and cell therapies. Supported by a global-standard GMP manufacturing infrastructure and a highly efficient, integrated commercialization model, the company has evolved into a globally competitive biopharmaceutical focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 26 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin.

Akeso Contacts:
Media: pr@akesobio.com
Investors: ir@akesobio.com

Coway Discloses Implementation Assessment of Its Corporate Value-Up Plan

  • Since announcing its Corporate Value-Up Plan in 2025, Coway has been seeing tangible progress across revenue growth, shareholder returns, financial soundness and governance
  • To date, the company has executed KRW 247.3 billion in shareholder returns, achieving the 40% return rate goal
  • Starting in FY2026, Coway will prioritize cash dividends to secure high-dividend company status and tax benefits for shareholders
  • Reporting an enhanced compliance rate on key governance indicators of 74%, Coway targets 93% by 2027

SEOUL, South Korea, Feb. 6, 2026 /PRNewswire/ — Coway Co., Ltd., the “Best Life Solution Company,” today announced an assessment of the implementation status of its Corporate Value-Up Plan, outlining concrete achievements to enhance shareholder value and detailing its mid- to long-term strategic roadmap.

Last year, Coway unveiled its Corporate Value-Up Plan, which includes the following key indicators to be achieved by 2027: achieving revenue exceeding KRW 5 trillion; maintaining a 40% shareholder return rate; managing a net debt-to-EBIT ratio of up to 2.5; and enhancing its governance frameworks.

Since announcing the plan, Coway has conducted several internal reviews of its implementation progress and has proactively prepared supplementary measures to enhance execution efficacy. This disclosure aims to transparently communicate an assessment of results to date, to convey future plans to shareholders and the market, and to reaffirm the credibility and positive impact of its value-up initiatives.

Early Progress Toward Revenue Goals: Accelerating the KRW 5 Trillion Roadmap

In 2025, Coway recorded KRW 4.96 trillion in revenue, a 15.2% year-over-year increase. This performance significantly outpaces the company’s targeted compound annual growth rate (CAGR) of 6.5%, placing Coway well ahead of schedule to exceed its KRW 5 trillion goal by 2027.

Coway sustained solid growth in 2025 through strengthened competitiveness in its domestic business and the continued expansion of its overseas operations. In the domestic market, steady growth in water purifier rental accounts served to reinforce the foundation of the company’s core business, while on the global front, revenue growth was driven by continual expansion at existing overseas subsidiaries, as well as rapid growth from newer entities.

This strong performance was fueled, in particular, by BEREX, Coway’s sleep and wellness brand, first launched in 2022 as part of Chairman Junhyuk Bang’s strategic vision to secure new growth engines. In 2025, BEREX generated KRW 719.9 billion in combined domestic and overseas revenue.

Alongside the launches of BEREX products to international markets and the expansion of product lineups across a variety of categories, in line with the Chairman’s strategy for global expansion, the contribution of overseas markets to Coway’s overall revenue increased to approximately 40% in 2025, further strengthening Coway’s presence on the global stage.

Delivering a 40% Shareholder Return Rate Through Balanced Execution

Coway successfully achieved a 40% total shareholder return rate in 2025, comprising KRW 247.3 billion. This was achieved through a balanced mix of KRW 137.3 billion in cash dividends and KRW 110.0 billion in treasury stock acquisitions. Notably, the company retired approximately 1.9 million treasury shares acquired in 2017 and 2024 in order to directly boost per-share value.

While maintaining the 40% return rate through 2027, Coway will prioritize cash dividends to satisfy “High-Dividend Company” requirements that enable the shareholders to benefit from separate taxation on dividend income. The company will also maintain a dividend payout ratio of at least 25% and increase the total dividend amount by more than 10% year-over-year. The remaining 15% of the return pool will be flexibly allocated between treasury stock purchases and additional cash dividends to maximize shareholder tax benefits and total yields.

Maintaining Financial Soundness and Stable Capital Structure Management

Alongside the expansion of growth investments and shareholder returns, Coway is working to manage its target capital structure in a manner that ensures financial stability. As of 2025, the company’s net debt-to-EBIT ratio stood at 2.1, and Coway plans to manage it up to 2.5 by 2027 through continued and consistent capital structure management.

In order to secure funds for growth investments, working capital and shareholder returns, Coway actively utilizes debt financing to enhance capital efficiency, all the while rigorously maintaining its credit rating risk so as to further strengthen long-term fiscal viability.

Strengthening Compliance Rates for Key Governance Indicators

Since first announcing its Corporate Value-Up Plan, Coway has reported an increase in its compliance rate on key governance indicators to 74%, a rise driven by an increase in the proportion of outside directors to 67% as well as the establishment of a Compensation Committee composed entirely of outside directors.

Coway has also outlined a mid- to long-term roadmap for its corporate governance advancement. In 2026, the company plans to establish an Internal Transaction Committee and a Senior Independent Director system to further enhance its corporate governance, and will also undertake amendments to its articles of incorporation in line with the recent revisions to South Korea’s Commercial Act. By 2027, Coway aims to reach a compliance rate on key governance indicators of 93% through measures such as the adoption of electronic voting and cumulative voting systems.

A Coway official said, “Since announcing our Corporate Value-Up Plan, we have delivered tangible results across our growth rate, shareholder returns and governance standards. Going forward, we will continue to monitor implementation of the plan closely using key indicators, and remain dedicated to a balanced approach that reinforces both investment in future growth engines and shareholder returns, thereby ensuring the steady enhancement of corporate value over the mid to long term.”

For additional details about Coway’s Corporate Value-Up Plan, please visit the company’s Investor Relations Page.

About Coway Co., Ltd.

Established in Korea in 1989, Coway, the “Best Life Solution Company,” is a leading home environment appliances company making people’s lives healthy and comfortable with innovative home appliances such as water purifiers, air purifiers, bidets, and mattresses. BEREX, the company’s sleep & wellness brand, aims to improve the quality of life through cutting-edge mattresses and massage chairs. Since being founded, Coway has become a leader in the home environment appliances industry, with intensive research, engineering, development, and customer service. The company has proven dedication to innovation with award-winning products, home health expertise, unrivaled market share, customer satisfaction, and brand recognition. Coway continues to innovate by diversifying product lines and accelerating overseas business in Malaysia, the USA, Thailand, China, Indonesia, Vietnam, and Europe, based on the business success in Korea. In 2025, the company launched Coway Life Solution, a premium elder care platform offering personalized care solutions tailored to different life stages. For more information, please visit http://www.coway.com/ or http://newsroom.coway.com.

 

Natural Diamonds Take Center Stage on the Red Carpet at the Grammy Awards

Today’s biggest stars express individuality and confidence with natural diamonds


LOS ANGELES, US – Media OutReach Newswire – 6 February 2026 – At this year’s GRAMMY Awards, the Red Carpet sparkled with natural diamonds punctuating the looks of today’s most celebrated music artists.

Natural diamonds take center stage on the red carpet at the Grammy Awards. From left to right: Addison Rae, Bad Bunny, Justin Bieber and Hailey Bieber, Olivia Dean
Natural diamonds take center stage on the red carpet at the Grammy Awards. From left to right: Addison Rae, Bad Bunny, Justin Bieber and Hailey Bieber, Olivia Dean

Leading artists, performers and presenters showed up for music’s biggest night in diamond jewelry looks that spoke to creativity, individuality, glamour and power. From nominees Olivia Dean and Sabrina Carpenter to presenter Keltie Knight’s choices, natural diamonds expressed not only the timeless glamour and brilliance they’re known for, but their ability to amplify personal style. Natural diamonds were spotted in a range of tones from icy whites to deep whiskeys, and in settings from platinum to rose gold. Just as Hollywood stars are hitting the Red Carpet this year in Desert diamonds, the biggest new trend in natural diamonds, musical artists are experimenting with a bolder diamond palette, creating a more personality-driven red carpet.

Desert diamonds
Desert diamonds, ranging from warm whites to deep whiskeys, were spotted everywhere, including on presenter Keltie Knight, who opted for unique diamond and yellow gold hoops by RENNA, as well as a smattering of yellow gold, fancy-shaped diamond solitaire rings from the brand. Highlights also included power player J Balvin who chose a clean and classic tuxedo paired with a large cushion cut yellow diamond ring that added a nice balance to the traditionally masculine look.

Simple Drops
Simple drop earrings emerged as a quiet standout at the GRAMMYs, proving that restraint can be just as impactful as large statement pieces. Addison Rae and Madison Beer leaned into effortless glamour, choosing sleek diamond drops that framed the face with subtle movement and modern elegance. Billie Eilish brought her signature edge, using pared-back diamond drops to balance her bold black and white suiting. Kelsea Ballerini elevated the look in Sabyasachi, where refined diamond drops added softness and romance, while Reba McEntire turned to Martin Katz for timeless brilliance, opting for classic diamond drops that were sure to catch the eye.

Diamond Hoops for Men
Men are increasingly embracing minimalist yet impactful diamond hoop earrings as a refined accessory choice. Bad Bunny paired his sharp Schiaparelli tuxedo with a single diamond hoop earring, bringing a subtle but polished sparkle to his look that perfectly balanced his experimental sartorial vibe. Kaytranada’s red carpet presence and inclination for understated yet stylish accessories suggest that simple diamond hoops align naturally with his fashion-forward aesthetic. This trend points to a broader moment in men’s red carpet jewelry: pared-back diamond hoops that provide polished shine without overpowering the rest of the ensemble, signaling a move toward jewelry that feels personal, versatile, and modern.

Rings
Rings at the GRAMMYs reflected a dual trend of bold expression and refined delicacy, underscoring natural diamonds’ versatility. Sabrina Carpenter complimented her look in Chopard, opting for diamond rings that delivered impact without overpowering her look, while Sombr also made a striking impression with a diamond ring that was perfect high-jewelry shine to go with his existing sequined ensemble. In contrast, Olivia Dean showcased a more delicate approach in Cartier High Jewelry, layering elegant diamond rings that emphasized timeless sophistication perfectly echoing her Chanel gown. Miley Cyrus made perhaps the boldest ring statement of the night with several diamond rings stacked and worn over leather gloves.

Necklaces
Necklaces at the GRAMMYs showcased how natural diamonds can define both quiet refinement and bold presence on the red carpet. On the delicate end of the spectrum, Charlotte Lawrence in Messika exemplified understated luxury with a finely crafted diamond necklace that traced the neckline proving that less is more. In contrast, Hailey and Justin Bieber turned heads with matching Lorraine Schwartz statement diamond neck pieces that anchored their looks. Tate McRae also grabbed attention with a 50 carat Lorraine Schwartz necklace, while Pharrell Williams elevated his ensemble with a striking diamond necklace that blended artistry and scale. Together, these moments underscored a versatile necklace trend: from minimalist diamonds that whispered elegance to oversized, expressive pieces that commanded attention. Natural diamonds continue to serve as dynamic anchors in personal style storytelling.

Hashtag: #ADiamondisForever #NaturalDiamonds #diamonds #GRAMMYS




The issuer is solely responsible for the content of this announcement.

About De Beers Group

Established in 1888, De Beers Group is the world’s leading diamond company with expertise in the exploration, mining, marketing and retailing of diamonds. Together with its joint venture partners, De Beers Group employs more than 20,000 people across the diamond pipeline and is the world’s largest diamond producer by value, with diamond mining operations in Botswana, Canada, Namibia and South Africa. Innovation sits at the heart of De Beers Group’s strategy as it develops a portfolio of offers that span the diamond value chain, including its jewellery houses, De Beers London and Forevermark, and other pioneering solutions such as diamond sourcing and traceability initiatives Tracr and GemFair. De Beers Group also provides leading services and technology to the diamond industry in the form of education and laboratory services and a wide range of diamond sorting, detection and classification technology services.

De Beers Group is committed to ‘,’ a holistic and integrated approach to sustainability that underpins our efforts to create meaningful impact for the people and places where our diamonds are

discovered. Building Forever focuses on three key areas where, through collaborations and partnerships around the globe, we have an enhanced ability to drive positive impact; Livelihoods, Climate and Nature. De Beers Group is a member of the Anglo American plc group. For further information, visit .

Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for ‘CART BP pro’ in Japan

– Secures distribution agreement to launch CART BP pro in the Japanese hospital and clinic market
– Leveraging proven technology with adoptions in 1,700+ medical institutions and national health insurance coverage in Korea

SEOUL, South Korea, Feb. 6, 2026 /PRNewswire/ — Sky Labs Inc. (CEO Jack Byunghwan Lee) announced on the 5th that it has entered into an exclusive distribution agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for the ring-type blood pressure monitor, ‘CART BP pro’, in the Japanese hospital and clinic market.

This agreement follows the memorandum of understanding (MoU) signed between the two companies in December 2024. Sky Labs initially explored global expansion opportunities through Korea Otsuka Pharmaceutical, and the introduction by the Korean affiliate led to formal discussions and negotiations with Otsuka’s headquarters. Such a collaboration represents a successful open-innovation case in which a Korean venture company leveraged the domestic subsidiary of a multinational corporation as a bridge to establish a partnership with its global headquarters.

Otsuka is a global pharmaceutical company providing a wide range of medical solutions worldwide, making it one of the most trusted companies in Japan’s healthcare landscape. By partnering with Otsuka and leveraging profound expertise in the cardiovascular field as well as its extensive distribution network, Sky Labs aims to reach a broader patient population and accelerate the adoption of CART BP pro across hospitals and clinics throughout Japan.

The number of hypertension patients in Japan is approximately 43 million, of whom an estimated 29% fail to achieve blood pressure control despite receiving treatment, and 33% are believed to be unaware of their condition.[1] Furthermore, as abnormal 24-hour blood pressure patterns and nocturnal hypertension are linked to increased risks of organ damage and cerebrovascular diseases, the clinical importance of 24-hour blood pressure monitoring is growing. Given these clinical requirements and the vast patient population, CART BP pro is expected to significantly contribute to the management of hypertensive patients in Japan, ranging from precise diagnosis and optimal treatment strategy development to systematic assessment of therapeutic effects.

CART BP pro has already demonstrated its technological prowess with tangible results in the Korean market. Following medical device approval from the Ministry of Food and Drug Safety (MFDS) in 2023, it gained clinical recognition in 2024 through national health insurance reimbursement approval.

Currently, the device is prescribed for 24-hour Ambulatory Blood Pressure Monitoring (ABPM) in over 1,700 medical institutions nationwide, including tertiary hospitals, surpassing 150,000 cumulative prescriptions within just one year since its domestic launch. This proven track record and clinical reliability in actual medical settings served as the key drivers for securing this exclusive distribution agreement.

Conventional blood pressure monitors use an air-inflated cuff to apply pressure and temporarily restrict blood flow for measurement. This method frequently causes discomfort and pain during measurement and can disrupt sleep during nighttime monitoring.

In contrast, CART BP pro utilizes photoplethysmography (PPG) technology to measure blood pressure without a cuff. This allows patients to measure their blood pressure comfortably during daily activities and sleep, while medical professionals can obtain stable data to provide appropriate treatment plans.

Jack Byunghwan Lee, CEO of Sky Labs, stated, “Starting with our entry into Japan, we will continue to validate our unparalleled blood pressure monitoring technology in the global market, while leaping forward as a leader in the global blood pressure monitoring industry.”

About Sky Labs https://skylabs.io/en/

Founded in September 2015, Sky Labs is a healthcare company that develops and operates “CART”, a ring-type medical device and platform for monitoring chronic disease patients. Since the first CART was developed in 2020 for atrial fibrillation monitoring using cardiac signals from optical sensors, the company has expanded its capabilities. In 2023, Sky Labs received medical device approval for “CART BP pro,” a ring-type monitor designed for 24-hour blood pressure measurement. In 2024, CART BP pro was recognized by the Health Insurance Review and Assessment Service (HIRA) under the existing medical procedure of ’24-hour ambulatory blood pressure monitoring’ (reimbursement code ‘E6547’), and is currently being prescribed in hospitals and clinics across Korea. Furthermore, in September 2025, the company launched “CART BP,” a consumer-grade ring-type blood pressure monitor, which is available through its official online store and various other online channels.

About Otsuka www.otsuka.co.jp/en/

Otsuka Pharmaceutical Co., Ltd. is a total healthcare company that focuses on each individual’s potential to enhance their well-being. Our medical-related business provides treatments and diagnostics for both physical and mental health. Our nutraceutical business supports daily health maintenance and improvement. Otsuka’s unique products and services are based on scientific evidence, under the guidance of our corporate philosophy: Otsuka-people creating new products for better health worldwide.

Media Inquiries
Inok Jung inok.jung@skylabs.io
Bomi Lee bomi.lee@skylabs.io

 

Why Trustworthy LLMs Must Define the Next Phase of AI

HO CHI MINH CITY, Vietnam, Feb. 6, 2026 /PRNewswire/ — Appier today announced a new corporate positioning centered on Agentic AI as a Service (AaaS), marking a pivotal shift in how software creates value in the AI era. As Agentic AI matures, software is no longer limited to responding to instructions—it can perceive intent, plan intelligently, take action, and continuously learn. This signals the arrival of the AaaS era, where AI agents work alongside humans to lead workflows, and intelligence becomes an active driver of business execution.

However, this shift also raises a critical question the industry can no longer ignore. While AI capabilities are advancing at extraordinary speed, we have built models that can write, analyze, predict, and persuade—yet we still cannot guarantee when they will be correct. In an era where AI agents are expected to act autonomously, uncertainty is no longer a technical inconvenience; it becomes a business risk that no amount of clever prompting can conceal.

As generative AI becomes embedded in business operations, the conversation is shifting. The question is no longer what AI can do. The question is whether we can trust it with decisions that matter. Because when a model can rewrite a customer contract, decide which audience to target next quarter, or generate code that touches production systems, “mostly reliable” is the same as “not reliable at all.”

Over the past year, research communities have been sounding the alarm: today’s LLMs are astonishingly capable and astonishingly fragile. They can produce perfect answers one minute and confidently incorrect ones the next, triggered by nothing more than a subtle change in phrasing or a slightly unfamiliar input. And because these models lack a true sense of uncertainty, they behave with the same confidence whether they are right or dangerously wrong.

This is not a small technical flaw. It is the central obstacle standing between AI as a novelty and AI as a business infrastructure. No enterprise can operate on top of a system that makes unpredictable errors, cannot explain itself, and does not recognize when it needs help. Yet this is exactly how most widely deployed models behave today.

That is why “trustworthy LLMs” must define the next era of AI, whether the industry is ready or not. Trust is not a feel-good aspiration. It is a prerequisite for real adoption. Businesses now need transparency about model data, clarity around safety constraints, mechanisms that prevent hallucinations from reaching customers, and governance frameworks that ensure models operate within brand, regulatory, and compliance boundaries, with systems that escalate to humans when uncertainty arises. These are not nice-to-haves. They are table stakes for AI that touches revenue, risk or reputation.

And here is the real shift: trust will become the new competitive advantage. The next generation of AI winners will not be the companies showing the flashiest demos, but the ones delivering models that behave predictably in the messy, ambiguous reality of enterprise work. The companies investing in architectural reliability, layered safeguards, and agentic oversight,  models that can plan, monitor, correct, and justify their own actions, will be the ones allowed into the workflows that actually matter. It is no longer enough for AI to be intelligent; it must also be accountable, and systems built with that philosophy at their core will define the next decade.

Bigger models alone will not close the trust gap. What we need now is architecture: hybrid systems that combine language models with verification mechanisms, retrieval grounding, domain constraints and transparent decision pathways. Intelligence without accountability will not survive contact with enterprise complexity.

The truth is simple. AI cannot become infrastructure until it becomes trustworthy. And the organizations that understand this, early, clearly and with conviction – will lead the next wave of enterprise transformation. Powerful AI may impress people, but trustworthy AI earns their confidence. In the long run, confidence is what scales.

The call to action is clear: every enterprise deploying AI must now treat trustworthiness as a first-order requirement, not a retrospective fix. That means demanding transparency from model providers, implementing oversight systems, investing in robustness testing, and building AI architectures that assume errors will happen and are designed to catch them.

The future of AI will not be defined by those who innovate the fastest, but by those who innovate the safest, and the companies that make trust their north star today will own the market tomorrow.

About Appier

Appier (TSE: 4180) is an AI-native AaaS company that empowers businesses to create value through cutting edge AdTech and MarTech solutions. Founded in 2012 with the vision of “Making AI Easy by Making Software Intelligent,” Appier helps businesses turn AI into ROI through its Ad Cloud, Personalization Cloud, and Data Cloud—each powered by Agentic AI that enables autonomous, adaptive and real-time decision-making. Today, Appier operates 17 offices across APAC, the US and EMEA, and is listed on the Tokyo Stock Exchange. Learn more at www.appier.com.

Cohesity Collaborates with Google Cloud to Deliver Secure Sandbox Capabilities and Comprehensive Threat Insights Designed to Eliminate Hidden Malware

Embedded Google Threat Intelligence capabilities, including Google Private Scanning, deliver powerful new ways to identify and remove risk

SINGAPORE, Feb. 6, 2026 /PRNewswire/ — Cohesity, the leader in AI-powered data security, today announced significant threat protection enhancements to the Cohesity Data Cloud, including a contextual display of Google Threat Intelligence insights and incorporating Google Private Scanning. These capabilities enable organizations to better identify, analyze, and eradicate malware before it can initiate a destructive cyberattack.

Unlike traditional backup security approaches that rely on static signatures, external tools, or manual workflows, Cohesity delivers native, intelligence-driven malware analysis directly within the cyber resilience platform, closing one of the industry’s most dangerous blind spots: undetected threats embedded in historical backup data.

As ransomware attacks, supply-chain compromises, and polymorphic malware grow in scale and sophistication, attackers are increasingly adopting stealthier, long-lived tactics to evade detection—making traditional signature-based tools insufficient, particularly for identifying low-and-slow threats hidden in historical backup data. Embedding Google Threat Intelligence into Cohesity Data Cloud enables real-time threat intelligence and secure malware detonation through a central management system, streamlining workflows between IT and security teams and enabling faster, more confident responses.

“Undetected malware hidden in backup data can both reinfect restored systems and, when properly scanned, reveal low-and-slow attacks that evade traditional detection,” said Vasu Murthy, Chief Product Officer, Cohesity. “By integrating Google Threat Intelligence, including Google Private Scanning, directly into the interface of Cohesity Data Cloud, we’re giving customers exceptional visibility and context into potential threats and powerful new ways to assess and eliminate risk—without fragmenting workflows or introducing operational complexity.”

Enable Faster, Higher-Confidence Threat Assessment at the Point of Recovery

The embedded Google Threat Intelligence capabilities surface detailed threat information, including investigative learnings from Mandiant’s incident response expertise and threat analysis, directly within the Cohesity Data Cloud user interface. IT and security teams can rapidly assess suspicious files using the latest indicators of compromise (IOCs), reputation data, and threat details without switching tools or relying on manual handoffs.

Safely Detonate Unknown Malware Before Restoring Data

Cohesity also introduced a leading “secure sandbox analysis” capability, enabled by Google Private Scanning. This feature safely detonates suspicious files in a sandbox environment while preserving customer data privacy and sovereignty. The feature brings Google’s frontline security expertise—typically reserved for SOC and IR teams—directly into the cyber resilience layer, where teams make recovery decisions. From there, Cohesity provides users with detailed behavioral analysis that reveals potential system changes, network activity, registry modifications, and other payload behavior. This allows teams to determine the actual risk posed by unknown or evasive malware before restoring data or reintroducing files into production. Because analysis occurs in a private scanning environment, organizations gain deep behavioral insight without exposing sensitive backup data to shared or third-party infrastructure.

Key Benefits

  • Faster threat identification and remediation by embedding real-time Google Threat Intelligence directly into Cohesity’s security scanning and response workflows.
  • Deeper, actionable insights through secure sandbox detonation and behavioral analysis of suspected malware
  • Improved collaboration between IT and security teams via a shared threat intelligence view
  • Stronger cyber resilience through differentiated, contextual threat protection capabilities

Deliver Superior Threat Detection Accuracy and Speed for Stronger Cyber Resilience

These enhancements build on Cohesity’s recent threat protection innovations, including rapid threat hunting and flexible scanning options, and closely follow the heels of Cohesity’s expanded collaboration with Google Cloud, announced in mid-December. With Google Cloud, Cohesity is helping enterprises identify threats others miss, recover more quickly, and enhance their overall cyber resilience.

These capabilities also complement Cohesity’s broader cyber resilience roadmap on Google Cloud. Cohesity FortKnox, a managed cyber vault solution, is now available on Google Cloud. FortKnox increases cyber resilience by maintaining an isolated, air-gapped copy of critical enterprise data, ensuring clean recovery even in worst-case scenarios where attackers compromise primary systems and traditional backups.

“At Google Cloud, we understand firsthand how attackers hide malicious payloads in places traditional security tools never look—including backups,” said Miton Adhikari, Head of Security OEM Partnerships. “By embedding Google Threat Intelligence and private sandboxing directly into Cohesity’s cyber resilience platform, organizations can detect what others miss and recover with greater speed and confidence.”

Cohesity is redefining cyber resilience by uniting intelligence-driven threat detection, secure analysis, and rapid recovery into a single platform—bringing frontline Google Cloud security expertise directly into the moment of recovery. The result is greater confidence in recovery and stronger protection against threats others miss.

Availability

The embedded Google Threat Intelligence and secure sandbox analysis capabilities are now generally available in Cohesity Data Cloud. For more information, please visit the related blog. The offering is also available on the Google Cloud Marketplace.

About Cohesity 

Cohesity protects, secures, and provides insights into the world’s data. As the leader in AI-powered data security, Cohesity helps organizations strengthen resilience, accelerate recovery, and reduce IT costs. With Zero Trust security and advanced AI/ML, Cohesity Data Cloud is trusted by customers in more than 140 countries, including 70% of the Fortune Global 500. Cohesity is also backed by industry leaders such as NVIDIA, Amazon, Google, IBM, Cisco, and HPE.

Cohesity is certified as a Great Place to Work in multiple countries. Follow Cohesity on LinkedIn and visit www.cohesity.com to learn more.